当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 利润表

安图生物

(603658)

  

流通市值:456.71亿  总市值:456.71亿
流通股本:5.86亿   总股本:5.86亿

利润表

按照会计年度查询:
报告期2021-03-312020-12-312020-09-302020-06-30
一、营业总收入817,001,562.132,978,131,605.362,047,341,075.71,205,779,467.25
营业收入817,001,562.132,978,131,605.362,047,341,075.71,205,779,467.25
二、营业总成本653,197,116.062,193,101,892.211,508,469,156.41938,478,581.65
营业成本347,544,549.561,198,723,245.95814,941,062496,989,544.36
营业税金及附加7,674,908.0125,145,911.9315,143,175.599,869,664.69
销售费用154,143,382.03464,670,716.43324,329,636.15212,724,262.95
管理费用37,783,338.32140,900,466.1592,464,175.1157,098,253.49
财务费用2,292,218.9520,863,408.1925,495,221.4913,060,148.83
资产减值损失-426,198.84-1,663,699.48-1,003,593.24-1,003,593.34
三、其他经营收益118,768.165,247,114.23----
允许价值变动净收益-145,852.4993,538.12-79,786.63211,746.12
投资净收益27,393,874.0749,888,462.8138,324,337.7925,149,784.94
联营、合营企业投资收益--4,704,389.8414,730,418.984,704,389.84
汇兑净收益--------
四、营业利润192,502,294.32856,366,411.43596,115,052.12316,497,006.21
营业外收入598,847.961,418,209.181,106,479.62970,523.78
营业外支出532,554.5713,252,053.5611,796,955.9210,776,221.05
非流动资产处置净损失--------
五、利润总额192,568,587.71844,532,567.05585,424,575.82306,691,308.94
所得税17,505,985.987,441,782.9965,470,249.7631,079,368.76
未确认的投资损失--------
六、净利润(百万元)171.48747.79514.3273.96
少数股东损益3,580,071.369,296,950.655,653,108.71,648,232.95
归属于母公司股东的净利润171,482,530.45747,793,833.41514,301,217.36273,963,707.23
七、每股收益0.381.741.20.64
基本每股收益0.381.741.20.64
稀释每股收益0.381.741.20.64
TOP↑